Health Economics and Outcomes Research (HEOR)

  • Home
  • Newsroom
  • Health Economics and Outcomes Research (HEOR)

Health Economics and Outcomes Research (HEOR)

  1. lut 28, 2025

What Does the 'Health Economics and Outcomes Research (HEOR)’ Mean?

Health Economics and Outcomes Research (HEOR) is a multidisciplinary field that evaluates the economic impact and patient outcomes of healthcare interventions. It combines principles from economics, epidemiology, and health policy to assess the value of medical treatments, drugs, and healthcare services.

HEOR studies analyze factors such as cost-effectiveness, quality of life improvements, and overall healthcare resource utilization. The findings from HEOR are used by healthcare providers, payers, and policymakers to make informed decisions about resource allocation, treatment guidelines, and reimbursement policies.

Why Is the 'Health Economics and Outcomes Research (HEOR)’ Important in Clinical Research?

HEOR plays a crucial role in clinical research by providing a comprehensive understanding of the real-world impact of medical interventions. It helps researchers and stakeholders evaluate not only the clinical efficacy of treatments but also their economic viability and effect on patient-reported outcomes, ensuring a more holistic approach to healthcare decision-making.

The importance of HEOR in clinical research is further emphasized by its ability to bridge the gap between clinical trial results and real-world application. By incorporating economic analyses and patient-centered outcomes, HEOR enables more informed decisions about resource allocation, treatment guidelines, and reimbursement policies, ultimately leading to more efficient and effective healthcare systems.

Good Practices and Procedures

  1. Conduct systematic literature reviews to identify relevant economic models and patient-reported outcome measures specific to the disease area being studied.
  2. Develop and validate disease-specific economic models that incorporate both direct and indirect costs associated with treatments and health outcomes.
  3. Utilize real-world evidence and claims data to supplement clinical trial results and enhance the generalizability of HEOR findings.
  4. Implement sensitivity analyses to account for uncertainties in cost estimates, clinical outcomes, and patient preferences across different healthcare settings.
  5. Engage with stakeholders, including patients, clinicians, and payers, throughout the HEOR process to ensure relevance and applicability of research outcomes.

Related Terms

Resources

How ACT EU Is Forcing a Global Approach to Trial Timelines

Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…

Axcellant at ICNC Berlin: Following the Future of Nuclear Cardiology – and helping bring it to clinical reality

The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…

Axcellant Establishes Advisory Board to Strengthen Clinical and Strategic Leadership

Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…